Sedmak D D, Meineke T A, Knechtges D S, Anderson J
Department of Pathology, Ohio State University College of Medicine, Columbus.
Mod Pathol. 1989 Sep;2(5):516-20.
The most important discriminant in staging carcinoma of the breast is the presence of positive axillary lymph nodes. In this study, we determined if 45 female breast cancer patients originally classified as lymph node-negative by standard light microscopy (SLM) could be more accurately classified by immunohistochemical (IH) examination of their lymph nodes with an anticytokeratin monoclonal antibody cocktail. Identical sections of lymph nodes were sequentially examined by SLM and IH. Eight nodes (1%) in a total of five patients (11%) were positive by SLM. In comparison, 12 nodes (1.5%) in a total of nine patients (20%) were positive by IH. Five nodes were positive by IH and negative by SLM. There was no correlation between IH-detected metastases and tumor size or patient age. The survival curve for patients with IH-detected metastases was significantly worse than that of patients without IH-detected metastases. IH detection methods may be an important adjunct in staging breast cancer patients.
乳腺癌分期中最重要的判别因素是腋窝淋巴结阳性。在本研究中,我们确定了45例最初经标准光学显微镜(SLM)判定为淋巴结阴性的女性乳腺癌患者,通过使用抗细胞角蛋白单克隆抗体混合物对其淋巴结进行免疫组织化学(IH)检查,是否能得到更准确的分类。对淋巴结的相同切片依次进行SLM和IH检查。在总共5例患者(11%)中,有8个淋巴结(1%)经SLM检查呈阳性。相比之下,在总共9例患者(20%)中,有12个淋巴结(1.5%)经IH检查呈阳性。有5个淋巴结经IH检查呈阳性但经SLM检查呈阴性。IH检测到的转移与肿瘤大小或患者年龄之间无相关性。经IH检测到转移的患者的生存曲线明显比未检测到转移的患者差。IH检测方法可能是乳腺癌患者分期的一项重要辅助手段。